Cardinal Health Inc (NYSE:CAH). shares have reached an all-time high, touching a price level of $116.4, marking a significant milestone for the healthcare services and products company. This peak comes amidst a robust year for Cardinal Health, which has seen its stock value surge by 25.15% over the past year. Investors and analysts are closely monitoring the company's performance, as this new all-time high could reflect both the strength of Cardinal Health's business operations and the broader industry's potential for growth. The company's strategic initiatives and market position have contributed to this impressive ascent, signaling strong investor confidence in its future prospects.
In other recent news, Cardinal Health reported strong first quarter results, surpassing analyst estimates and subsequently raising its full-year earnings guidance. The healthcare services company posted adjusted earnings per share of $1.88, outperforming the projected $1.62, and reported revenue of $52.3 billion, exceeding the forecasted $50.9 billion. Cardinal Health now projects full-year 2025 adjusted earnings per share to be between $7.75 and $7.90, an increase from its previous outlook.
These are recent developments that show a positive trend in the company's financial performance. CEO Jason Hollar attributed this success to the strong performance of the Pharmaceutical and Specialty Solutions segment, which has led the company to raise its profit growth outlook for this segment to 4-6%, up from 1-3%.
However, the company has lowered its profit forecast for its Global Medical Products and Distribution segment to $140-$175 million due to higher health and welfare costs. Despite this, Cardinal Health has increased its adjusted free cash flow expectations to $1.0-$1.5 billion, up from approximately $1.0 billion. The company's first quarter revenue decreased by 4% year over year to $52.3 billion, but when excluding the impact of a large customer contract expiration, it increased by 15%.
InvestingPro Insights
Cardinal Health's recent all-time high is supported by several key financial metrics and insights from InvestingPro. The company's market capitalization stands at $27.79 billion, reflecting its significant presence in the Healthcare Providers & Services industry. Cardinal Health has demonstrated strong revenue growth, with a 10.66% increase in the last twelve months, reaching $226.83 billion. This growth trend is further emphasized by an 11.77% quarterly revenue increase in the most recent fiscal quarter.
InvestingPro Tips highlight Cardinal Health's financial strength and shareholder-friendly policies. The company has maintained dividend payments for 42 consecutive years and has raised its dividend for 36 consecutive years, showcasing its commitment to returning value to shareholders. This is particularly noteworthy given the company's impressive 18.21% total return over the past year, aligning with the stock's recent all-time high.
Additionally, Cardinal Health is trading at a low P/E ratio relative to its near-term earnings growth, with an adjusted P/E ratio of 16.31 for the last twelve months. This suggests that despite the stock's strong performance, there may still be room for further appreciation based on the company's earnings potential.
For investors seeking more comprehensive analysis, InvestingPro offers 16 additional tips for Cardinal Health, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.